x

Verve Therapeutics, Inc. (Nasdaq:VERV)

Health Care/Life Sciences • Biotechnology
CIK 1840574
Company

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Sekar Kathiresan, Kiran Musunuru, Keith J. Joung, Issi Rozen, Sekar Kathiresan, Burt A. Adelman and Barry Ticho in 2018 and is headquartered in Boston, MA.

Address
201 Brookline Avenue
Suite 601
Boston, Massachusetts 02215
Employees
255
Stock Info
Close
$15.14
Day Range
14.84 - 16.05
52 Week Range
8.22 - 21.42
Average volume
1.18M
Short Interest
12.59M (02/15/24)
% of Float Shorted
22.97%
Market Cap
$1.24B
Revenue
$11.76M
Net Income
N/A
2020 Sales Growth
N/A
Rev. per Employee
$46.11K
P/E Ratio
N/A
EPS
-$3.13
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
Sekar Kathiresan MD
Chairman
Burt A Adelman MD
Independent Director
Sheila A Mikhail MBA, CPA
Independent Director
Alexander Gery Cumbo
Independent Director
Lonnel Coats
Independent Director
Krishna Yeshwant MD, MBA
Independent Director
Michael F MacLean
SEC filings
DateFormEvent
9 Sep, 2024 SC 13G/A
8 Aug, 2024 8-K
8 Aug, 2024 10-Q
2 Jul, 2024 4
28 Jun, 2024 8-K
28 Jun, 2024 8-K/A
28 Jun, 2024 4
28 Jun, 2024 3
28 Jun, 2024 3
28 Jun, 2024 3
28 Jun, 2024 4
28 Jun, 2024 4
28 Jun, 2024 4
28 Jun, 2024 4
28 Jun, 2024 4
28 Jun, 2024 4
28 Jun, 2024 4
27 Jun, 2024 SC 13G
25 Jun, 2024 4
25 Jun, 2024 3
7 Jun, 2024 8-K
31 May, 2024 8-K
15 May, 2024 4
8 May, 2024 10-Q
8 May, 2024 8-K
26 Apr, 2024 DEF 14A
26 Apr, 2024 DEFA14A
26 Apr, 2024 ARS
3 Apr, 2024 4
2 Apr, 2024 8-K
27 Feb, 2024 10-K
27 Feb, 2024 8-K
27 Feb, 2024 S-8
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
16 Feb, 2024 4
13 Feb, 2024 SC 13G/A
9 Feb, 2024 5
29 Jan, 2024 SC 13G/A
29 Jan, 2024 SC 13G
23 Jan, 2024 SC 13G/A
16 Jan, 2024 SCHEDULE 1
11 Dec, 2023 SC 13G/A
11 Dec, 2023 SC 13G/A
5 Dec, 2023 4
5 Dec, 2023 3
1 Dec, 2023 4
29 Nov, 2023 424B5
29 Nov, 2023 8-K
28 Nov, 2023 424B5
13 Nov, 2023 8-K
7 Nov, 2023 10-Q
7 Nov, 2023 8-K
23 Oct, 2023 8-K
19 Sep, 2023 4
19 Sep, 2023 3
10 Aug, 2023 10-Q
10 Aug, 2023 8-K
16 Jun, 2023 8-K
15 Jun, 2023 8-K
15 May, 2023 10-Q
15 May, 2023 8-K
28 Apr, 2023 DEF 14A
28 Apr, 2023 ARS
28 Apr, 2023 DEFA14A
2 Mar, 2023 10-K
2 Mar, 2023 8-K
2 Mar, 2023 S-8
23 Feb, 2023 3
17 Feb, 2023 8-K
16 Feb, 2023 4
16 Feb, 2023 4
16 Feb, 2023 4
16 Feb, 2023 4
16 Feb, 2023 4
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
13 Feb, 2023 SC 13G/A
10 Feb, 2023 SC 13G
10 Feb, 2023 SC 13G
10 Feb, 2023 SC 13G/A
9 Feb, 2023 SC 13G
9 Feb, 2023 SC 13G/A
7 Feb, 2023 SC 13G
6 Feb, 2023 SC 13G/A
16 Dec, 2022 4
5 Dec, 2022 8-K
2 Dec, 2022 4
1 Dec, 2022 4
8 Nov, 2022 4
8 Nov, 2022 4
7 Nov, 2022 8-K
7 Nov, 2022 10-Q
4 Nov, 2022 4
4 Nov, 2022 4
2 Nov, 2022 4
2 Nov, 2022 4
1 Nov, 2022 4
5 Oct, 2022 4
27 Sep, 2022 4
23 Sep, 2022 S-3ASR
29 Aug, 2022 4
11 Aug, 2022 4
10 Aug, 2022 SC 13G/A
9 Aug, 2022 8-K
9 Aug, 2022 4
9 Aug, 2022 3
9 Aug, 2022 10-Q
28 Jul, 2022 4
22 Jul, 2022 4
21 Jul, 2022 424B5
21 Jul, 2022 8-K
21 Jul, 2022 4
21 Jul, 2022 8-K
20 Jul, 2022 424B5
20 Jul, 2022 8-K
15 Jul, 2022 4
15 Jul, 2022 4
14 Jul, 2022 4
12 Jul, 2022 EFFECT
12 Jul, 2022 8-K
8 Jul, 2022 CORRESP
7 Jul, 2022 UPLOAD
7 Jul, 2022 8-K
6 Jul, 2022 4
1 Jul, 2022 4
1 Jul, 2022 S-3
13 Jun, 2022 4
13 Jun, 2022 4
13 Jun, 2022 4
13 Jun, 2022 4
13 Jun, 2022 8-K
13 Jun, 2022 3
13 Jun, 2022 4
13 Jun, 2022 4
13 May, 2022 4
10 May, 2022 8-K
10 May, 2022 10-Q
29 Apr, 2022 DEF 14A
29 Apr, 2022 DEFA14A
22 Mar, 2022 4
17 Mar, 2022 4
14 Mar, 2022 8-K
14 Mar, 2022 S-8
14 Mar, 2022 10-K
11 Mar, 2022 4
15 Feb, 2022 4
15 Feb, 2022 4
15 Feb, 2022 4
15 Feb, 2022 4
14 Feb, 2022 SC 13G
14 Feb, 2022 SC 13G/A
11 Feb, 2022 4
9 Feb, 2022 SC 13G
9 Feb, 2022 SC 13G/A
4 Feb, 2022 SC 13G/A
4 Feb, 2022 SC 13G
3 Feb, 2022 4
28 Jan, 2022 4
24 Jan, 2022 SC 13G
6 Jan, 2022 4
29 Dec, 2021 4
28 Dec, 2021 3
28 Dec, 2021 SC 13G/A
27 Dec, 2021 4
27 Dec, 2021 4
17 Dec, 2021 4
6 Dec, 2021 4
6 Dec, 2021 4
30 Nov, 2021 3
30 Nov, 2021 4
29 Nov, 2021 8-K
10 Nov, 2021 10-Q
10 Nov, 2021 8-K
24 Aug, 2021 8-K
16 Aug, 2021 10-Q/A
12 Aug, 2021 10-Q
12 Aug, 2021 8-K
28 Jun, 2021 SC 13G
23 Jun, 2021 4
23 Jun, 2021 4
23 Jun, 2021 SC 13G
23 Jun, 2021 SC 13G
23 Jun, 2021 4
23 Jun, 2021 4
23 Jun, 2021 4
23 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
22 Jun, 2021 4
21 Jun, 2021 4
21 Jun, 2021 8-K
21 Jun, 2021 4
21 Jun, 2021 4
21 Jun, 2021 4
21 Jun, 2021 4
17 Jun, 2021 S-8
17 Jun, 2021 424B4 IPO completed
16 Jun, 2021 S-1MEF
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 3
16 Jun, 2021 EFFECT
16 Jun, 2021 SEC STAFF
15 Jun, 2021 CERT
14 Jun, 2021 S-1/A
14 Jun, 2021 CORRESP
14 Jun, 2021 CORRESP
11 Jun, 2021 8-A12B
4 Jun, 2021 CORRESP
28 May, 2021 CORRESP
28 May, 2021 S-1
13 May, 2021 UPLOAD
13 May, 2021 SEC STAFF
16 Apr, 2021 DRS
22 Jan, 2021 D
Last update:2024-03-06 13:29:07.332068
Verve Therapeutics, Inc. by TradingView

Sign Up to Subscribe